Enhanced mitochondrial superoxide in hyperglycemic endothelial cells: direct measurements and formation of hydrogen peroxide and peroxynitrite
Hyperglycemic challenge to bovine aortic endothelial cells (BAECs) increases oxidant formation and cell damage that are abolished by MnSOD overexpression, implying mitochondrial superoxide (O2•−) as a central mediator. However, mitochondrial O2•−and its steady-state concentrations have not been measured directly yet. Therefore, we aimed to detect and quantify O2•−through different techniques, along with the oxidants derived from it. Mitochondrial aconitase, a sensitive target of O2•−, was inactivated 60% in BAECs incubated in 30 mM glucose (hyperglycemic condition) with respect to cells incubated in 5 mM glucose (normoglycemic condition). Under hyperglycemic conditions, increased oxidation of the mitochondrially targeted hydroethidine derivative (MitoSOX) to hydroxyethidium, the product of the reaction with O2•−, could be specifically detected. An 8.8-fold increase in mitochondrial O2•−steady-state concentration (to 250 pM) and formation rate (to 6 μM/s) was estimated. Superoxide formation increased the intracellular concentration of both hydrogen peroxide, measured as 3-amino-2,4,5-triazole-mediated inactivation of catalase, and nitric oxide-derived oxidants (i.e., peroxynitrite), evidenced by immunochemical detection of 3-nitrotyrosine. Oxidant formation was further evaluated by chloromethyl dichlorodihydrofluorescein (CM-H2DCF) oxidation. Exposure to hyperglycemic conditions triggered the oxidation of CM-H2DCF and was significantly reduced by pharmacological agents that lower the mitochondrial membrane potential, inhibit electron transport (i.e., myxothiazol), and scavenge mitochondrial oxidants (i.e., MitoQ). In BAECs devoid of mitochondria (rho0cells), hyperglycemic conditions did not increase CM-H2DCF oxidation. Mitochondrial O2•−formation in hyperglycemic conditions was associated with increased glucose metabolization in the Krebs cycle and hyperpolarization of the mitochondrial membrane.
Top-30
Journals
|
1
2
3
4
5
6
7
8
|
|
|
Free Radical Biology and Medicine
8 publications, 8.51%
|
|
|
Free Radical Research
4 publications, 4.26%
|
|
|
American Journal of Physiology - Heart and Circulatory Physiology
4 publications, 4.26%
|
|
|
Antioxidants and Redox Signaling
3 publications, 3.19%
|
|
|
PLoS ONE
3 publications, 3.19%
|
|
|
Proceedings of the National Academy of Sciences of the United States of America
3 publications, 3.19%
|
|
|
Arteriosclerosis, Thrombosis, and Vascular Biology
2 publications, 2.13%
|
|
|
Antioxidants
2 publications, 2.13%
|
|
|
Circulation Research
2 publications, 2.13%
|
|
|
International Journal of Molecular Sciences
2 publications, 2.13%
|
|
|
Frontiers in Physiology
2 publications, 2.13%
|
|
|
Journal of Biological Chemistry
2 publications, 2.13%
|
|
|
Archives of Biochemistry and Biophysics
2 publications, 2.13%
|
|
|
Acta Physiologica
2 publications, 2.13%
|
|
|
Cardiovascular Research
2 publications, 2.13%
|
|
|
American Journal of Physiology - Cell Physiology
2 publications, 2.13%
|
|
|
Journal of Pharmacology and Experimental Therapeutics
1 publication, 1.06%
|
|
|
Biochemical Society Transactions
1 publication, 1.06%
|
|
|
Journal of Neurosurgical Anesthesiology
1 publication, 1.06%
|
|
|
Frontiers in Cell and Developmental Biology
1 publication, 1.06%
|
|
|
Molecular Medicine
1 publication, 1.06%
|
|
|
Cell Biochemistry and Biophysics
1 publication, 1.06%
|
|
|
Cardiovascular Diabetology
1 publication, 1.06%
|
|
|
Cellular and Molecular Life Sciences
1 publication, 1.06%
|
|
|
Scientific Reports
1 publication, 1.06%
|
|
|
Journal of Chromatography A
1 publication, 1.06%
|
|
|
Life Sciences
1 publication, 1.06%
|
|
|
Journal of Molecular and Cellular Cardiology
1 publication, 1.06%
|
|
|
Nitric Oxide - Biology and Chemistry
1 publication, 1.06%
|
|
|
1
2
3
4
5
6
7
8
|
Publishers
|
5
10
15
20
25
30
|
|
|
Elsevier
28 publications, 29.79%
|
|
|
American Physiological Society
7 publications, 7.45%
|
|
|
MDPI
6 publications, 6.38%
|
|
|
Springer Nature
6 publications, 6.38%
|
|
|
Taylor & Francis
6 publications, 6.38%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
5 publications, 5.32%
|
|
|
Frontiers Media S.A.
5 publications, 5.32%
|
|
|
Wiley
4 publications, 4.26%
|
|
|
Oxford University Press
4 publications, 4.26%
|
|
|
Mary Ann Liebert
3 publications, 3.19%
|
|
|
Public Library of Science (PLoS)
3 publications, 3.19%
|
|
|
American Chemical Society (ACS)
3 publications, 3.19%
|
|
|
Hindawi Limited
3 publications, 3.19%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
3 publications, 3.19%
|
|
|
American Society for Biochemistry and Molecular Biology
2 publications, 2.13%
|
|
|
American Society for Pharmacology and Experimental Therapeutics
1 publication, 1.06%
|
|
|
Portland Press
1 publication, 1.06%
|
|
|
Federation of American Societies for Experimental Biology (FASEB)
1 publication, 1.06%
|
|
|
Society for the Study of Reproduction
1 publication, 1.06%
|
|
|
The Japan Endocrine Society
1 publication, 1.06%
|
|
|
IntechOpen
1 publication, 1.06%
|
|
|
5
10
15
20
25
30
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.